Clinical Trial Update: Antiproteinuric Effect of Valsartan and Lisinopril [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses the antiproteinuric effects of combining valsartan (ARB) and lisinopril (ACE inhibitor) in patients with hypertension and diabetic n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Lisinopril (Lisinopril)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Diabetic Nephropathy | Phase 4 | Status: COMPLETED